Trial Outcomes & Findings for Combination of Buffered Anesthetic to Treat Mandibular Molars (NCT NCT06047366)
NCT ID: NCT06047366
Last Updated: 2025-05-13
Results Overview
Patient will report their comfort during treatment based on a visual analogue scale (VAS) graphic. Visual analog scale (VAS) is based on a scale of 0-10 related to patient comfort. A VAS score of 10 would mean the patient was extremely uncomfortable during treatment indicating there was inadequate anesthesia. A VAS score of 0 indicates no pain.
TERMINATED
PHASE4
40 participants
Up to 20 minutes post-drug administration
2025-05-13
Participant Flow
Participant milestones
| Measure |
Buffered
Buffered 2% lidocaine with 1:100,000 epinephrine Buffered 4% articaine with 1:100,000 epinephrine Buffered 3% mepivacaine Buffered local anesthetic (addition of sodium bicarbonate to make a 10% buffered solution)
Sodium bicarbonate: Onpharma's Onset sodium bicarbonate buffer to be added to a standard cartridge of dental local anesthetic
Lidocaine w/ epi: Septodont's standard formulation of 2% lidocaine with epinephrine
Articaine w/ epi: Septodont's standard formulation of 4% articaine with epinephrine
Mepivacaine plain: Septodont's standard formulation of 3% mepivacaine
|
Unbuffered
Unbuffered 2% lidocaine with 1:100,000 epinephrine Unbuffered 4% articaine with 1:100,000 epinephrine Unbuffered 3% mepivacaine Standard local anesthetics
Lidocaine w/ epi: Septodont's standard formulation of 2% lidocaine with epinephrine
Articaine w/ epi: Septodont's standard formulation of 4% articaine with epinephrine
Mepivacaine plain: Septodont's standard formulation of 3% mepivacaine
|
|---|---|---|
|
Overall Study
STARTED
|
20
|
20
|
|
Overall Study
COMPLETED
|
20
|
20
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Buffered
n=20 Participants
Buffered 2% lidocaine with 1:100,000 epinephrine Buffered 4% articaine with 1:100,000 epinephrine Buffered 3% mepivacaine Buffered local anesthetic (addition of sodium bicarbonate to make a 10% buffered solution)
Sodium bicarbonate: Onpharma's Onset sodium bicarbonate buffer to be added to a standard cartridge of dental local anesthetic
Lidocaine w/ epi: Septodont's standard formulation of 2% lidocaine with epinephrine
Articaine w/ epi: Septodont's standard formulation of 4% articaine with epinephrine
Mepivacaine plain: Septodont's standard formulation of 3% mepivacaine
|
Unbuffered
n=20 Participants
Unbuffered 2% lidocaine with 1:100,000 epinephrine Unbuffered 4% articaine with 1:100,000 epinephrine Unbuffered 3% mepivacaine Standard local anesthetics
Lidocaine w/ epi: Septodont's standard formulation of 2% lidocaine with epinephrine
Articaine w/ epi: Septodont's standard formulation of 4% articaine with epinephrine
Mepivacaine plain: Septodont's standard formulation of 3% mepivacaine
|
Total
n=40 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=20 Participants
|
0 Participants
n=20 Participants
|
0 Participants
n=40 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
20 Participants
n=20 Participants
|
20 Participants
n=20 Participants
|
40 Participants
n=40 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=20 Participants
|
0 Participants
n=20 Participants
|
0 Participants
n=40 Participants
|
|
Age, Continuous
|
39 years
n=20 Participants
|
28 years
n=20 Participants
|
33.5 years
n=40 Participants
|
|
Sex: Female, Male
Female
|
12 Participants
n=20 Participants
|
13 Participants
n=20 Participants
|
25 Participants
n=40 Participants
|
|
Sex: Female, Male
Male
|
8 Participants
n=20 Participants
|
7 Participants
n=20 Participants
|
15 Participants
n=40 Participants
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
Region of Enrollment
United States
|
20 participants
n=20 Participants
|
20 participants
n=20 Participants
|
40 participants
n=40 Participants
|
PRIMARY outcome
Timeframe: Up to 20 minutes post-drug administrationPopulation: Patients who achieved profound pulpal anesthesia
Patient will report their comfort during treatment based on a visual analogue scale (VAS) graphic. Visual analog scale (VAS) is based on a scale of 0-10 related to patient comfort. A VAS score of 10 would mean the patient was extremely uncomfortable during treatment indicating there was inadequate anesthesia. A VAS score of 0 indicates no pain.
Outcome measures
| Measure |
Buffered
n=17 Participants
Buffered 2% lidocaine with 1:100,000 epinephrine Buffered 4% articaine with 1:100,000 epinephrine Buffered 3% mepivacaine Buffered local anesthetic (addition of sodium bicarbonate to make a 10% buffered solution)
Sodium bicarbonate: Onpharma's Onset sodium bicarbonate buffer to be added to a standard cartridge of dental local anesthetic
Lidocaine w/ epi: Septodont's standard formulation of 2% lidocaine with epinephrine
Articaine w/ epi: Septodont's standard formulation of 4% articaine with epinephrine
Mepivacaine plain: Septodont's standard formulation of 3% mepivacaine
|
Unbuffered
n=15 Participants
Unbuffered 2% lidocaine with 1:100,000 epinephrine Unbuffered 4% articaine with 1:100,000 epinephrine Unbuffered 3% mepivacaine Standard local anesthetics
Lidocaine w/ epi: Septodont's standard formulation of 2% lidocaine with epinephrine
Articaine w/ epi: Septodont's standard formulation of 4% articaine with epinephrine
Mepivacaine plain: Septodont's standard formulation of 3% mepivacaine
|
|---|---|---|
|
Median Visual Analogue Scale (VAS) Score as a Measure of Profoundness of Pulpal Anesthesia
|
0 units on a scale
Interval 0.0 to 2.0
|
0 units on a scale
Interval 0.0 to 0.0
|
SECONDARY outcome
Timeframe: Up to 15 minutes post-drug administrationAn electronic pulp tester will be used to assess anesthesia after anesthetic is administered. The median time needed to achieve profound pulpal anesthesia for the two groups will be calculated using the Kaplan-Meier method and compared with a log-rank test, with patients who failed to achieve profound pulpal anesthesia censored at 15 minutes.
Outcome measures
| Measure |
Buffered
n=20 Participants
Buffered 2% lidocaine with 1:100,000 epinephrine Buffered 4% articaine with 1:100,000 epinephrine Buffered 3% mepivacaine Buffered local anesthetic (addition of sodium bicarbonate to make a 10% buffered solution)
Sodium bicarbonate: Onpharma's Onset sodium bicarbonate buffer to be added to a standard cartridge of dental local anesthetic
Lidocaine w/ epi: Septodont's standard formulation of 2% lidocaine with epinephrine
Articaine w/ epi: Septodont's standard formulation of 4% articaine with epinephrine
Mepivacaine plain: Septodont's standard formulation of 3% mepivacaine
|
Unbuffered
n=20 Participants
Unbuffered 2% lidocaine with 1:100,000 epinephrine Unbuffered 4% articaine with 1:100,000 epinephrine Unbuffered 3% mepivacaine Standard local anesthetics
Lidocaine w/ epi: Septodont's standard formulation of 2% lidocaine with epinephrine
Articaine w/ epi: Septodont's standard formulation of 4% articaine with epinephrine
Mepivacaine plain: Septodont's standard formulation of 3% mepivacaine
|
|---|---|---|
|
Median Time to Profound Pulpal Anesthesia
|
5.28 minutes
Interval 4.22 to 6.17
|
7.96 minutes
Interval 5.5 to 10.15
|
Adverse Events
Buffered
Unbuffered
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place